Ecole Polytechnique Federale de Lausanne

The École polytechnique fédérale de Lausanne (EPFL) is one of the two Swiss Federal Institutes of Technology and is located in Lausanne, Switzerland. The school was founded by the Swiss Federal Government with the stated mission to: The sister institution in the German-speaking part of Switzerland is the Eidgenössische Technische Hochschule Zürich (ETH Zürich or ETHZ). Associated with several specialised research institutes, the two sister institutes form the ETH Domain, which is directly dependent on the Federal Department of Home Affairs. EPFL is ranked among the top universities in the world. Founded in 1853 as a private school under the name École Spéciale de Lausanne, it became the technical department of the public Académie de Lausanne in 1869. When the latter was reorganized and acquired the status of a university in 1890, the technical faculty changed its name to École d'Ingénieurs de l'Université de Lausanne. In 1946, it was renamed the École polytechnique de l'Université de Lausanne (EPUL).

Address
Route Cantonale, Lausanne, Switzerland

Some content from Wikipedia, licensed under CC BY-SA

Antibiotics: A new understanding of sulfonamide nervous system side effects

Since the discovery of Prontosil in 1932, sulfonamide antibiotics have been used to combat a wide spectrum of bacterial infections, from acne to chlamydia and pneumonia. However, their side effects can include serious neurological ...

Medical research created May 23, 2013 | popularity 3 / 5 (1) | comments 0 | with audio podcast

Slowing the aging process—only with antibiotics

Swiss scientists reveal the mechanism responsible for aging hidden deep within mitochondria—and dramatically slow it down in worms by administering antibiotics to the young.

Medical research created May 22, 2013 | popularity 4.9 / 5 (13) | comments 2 | with audio podcast

Securely storing and interpreting the genome

At a time when sequencing the genome is becoming democratized, questions have arisen about the interpretation of these data and their secure storage. Sophia Genetics, an EPFL Science Park start-up, specializes in this. The ...

Genetics created Apr 19, 2013 | popularity not rated yet | comments 0

Peptides for the treatment of severe diseases

A new class of drugs for the treatment of severe diseases such as cancer and autoimmune diseases is developed by the start-up Bicycle Therapeutics. The company is generating bicyclic peptides that can selectively ...

Medical research created Apr 15, 2013 | popularity 5 / 5 (1) | comments 0

A 'micro-tap' for treating glaucoma

A tiny, EPFL-designed implantable device that can be positioned within the eye and controlled remotely may well revolutionize the treatment of glaucoma. The device should be through testing this year and ...

Ophthalmology created Mar 25, 2013 | popularity not rated yet | comments 0 | with audio podcast

Cellular bells: Key step in manufacture of red blood cells decoded

A healthy adult must generate as many as one hundred billion new red blood cells each day, to maintain the numbers circulating in his blood. A team of EPFL researchers has identified a key step in the process by which red ...

Medical research created Mar 14, 2013 | popularity 5 / 5 (4) | comments 0 | with audio podcast

The right dose for oncology

EPFL researchers develop a tool for oncologists using the electrical signature of cancer cells to get just the right treatment dosage for each patient.

Cancer created Mar 04, 2013 | popularity 2 / 5 (2) | comments 0

Fighting disease deep inside the brain

Some 90,000 patients per year are treated for Parkinson's disease, a number that is expected to rise by 25 percent annually. Deep Brain Stimulation (DBS), which consists of electrically stimulating the central or peripheral ...

Parkinson's & Movement disorders created Feb 18, 2013 | popularity 5 / 5 (3) | comments 0

The quest for a better bionic hand

For an amputee, replacing a missing limb with a functional prosthetic can alleviate physical or emotional distress and mean a return of vocational ability or cosmetics. Studies show, however, that up to 50 percent of hand ...

Medical research created Feb 18, 2013 | popularity not rated yet | comments 0

When the mind controls the machines

More than a hundred patients suffering from severe motor impairments have voluntarily participated in the development of non-invasive brain-machine interfaces. The main purpose of these machines is to allow ...

Neuroscience created Jan 24, 2013 | popularity 5 / 5 (3) | comments 0 | with audio podcast

Childhood trauma leaves its mark on the brain

It is well known that violent adults often have a history of childhood psychological trauma. Some of these individuals exhibit very real, physical alterations in a part of the brain called the orbitofrontal ...

Psychology & Psychiatry created Jan 15, 2013 | popularity 4.5 / 5 (6) | comments 1 | with audio podcast

Autoimmune disease—retraining white blood cells

Symptoms of an autoimmune disease disappeared after a team of scientists retrained the white blood cells. This method is extremely promising for treating diseases such as type I diabetes and multiple sclerosis.

Immunology created Dec 17, 2012 | popularity 5 / 5 (5) | comments 0 | with audio podcast

Scientists develop new method for 'extremely' early cancer detection

It may soon be possible to test a person for cancer with just a drop of their blood and a small machine. As part of a European research project, scientists have developed a device for detecting the HSP70 protein, which is ...

Cancer created Nov 02, 2012 | popularity 4.5 / 5 (2) | comments 0 | with audio podcast

EPFL and Harvard join forces to diagnose hearing loss

Researchers at EPFL and Harvard Medical School have joined forces to develop an imaging technique that can provide in situ observations of the internal ear, an area which has until now been inaccessible. ...

Medical research created Oct 17, 2012 | popularity not rated yet | comments 0

In cancer, an embryonic gene-silencing mechanism gone awry

There are some genes that are only activated in the very first days of an embryo's existence. Once they have accomplished their task, they are shut down forever, unlike most of our genes, which remain active throughout our ...

Genetics created Oct 04, 2012 | popularity not rated yet | comments 0